Differential (Click to cross reference) adverse drug reaction Alzheimer's disease Alzheimer's disease, treatment of asymptomatic brain atrophy cerebrovascular accident cerebrovascular accident, prevention of cholesterol cholesterol, LDL Clinical Pathologic Conference(C.P.C.) complications coronary artery disease creatine phosphokinase(CPK)elevated dementia, prevention of dementia, treatment of disability, neurological drug induced neurologic disorders drug interactions efficacy electromyogram eosinophilia eosinophilic fasciitis fibrillations gadolinium gemfibrozil HMGcoA reductase inhibitors human diploid cell rabies vaccine hyporeflexia iatrogenic neurologic disorders immunomodulation intellectual deficit intelligence quotient leg weakness, bilateral lipid lowering agent MRI MRI, abnormal MRI, contrast enhanced multiple sclerosis multiple sclerosis, relapsing multiple sclerosis, treatment of muscle biopsy muscle pain myopathy myopathy, necrotizing myopathy, toxic myotonic discharges negative neurofibromatosis 1 neuroprotective agents pain, leg paresthesias pravastatin prevention of neurologic disorders renal failure review article rhabdomyolysis risk factors risk-benefit assessment safety simvastatin statin therapy statin therapy, discontinuation statin therapy, dose symptomatic treatment of neurologic disorder walking, difficulty with weakness weakness, generalized weakness, progressive

Showing articles 0 to 9 of 9 Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial Lancet 383:2213-2221, Chataway, J.,et al, 2014 Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins NEJM 36:944-954, Case 7-2012, 2012 Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy NEJM 365:285-287, Egan, A.,et al, 2011 A Randomized, Double-Blind, Placebo Controlled Trial of Simvastatin to Treat Alzheimer Disease Neurol 77:556-563, Sano, M.,et al, 2011 Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1: A Randomized Controlled Trial JAMA 300:287-294, Krab,L.C.,et al., 2008 Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004 Oral Simvastin Treatment in Relapsing-Remitting Multiple Sclerosis Lancet 363:1607-1608,1570, Vollmer,T.,et al, 2004 Eosinophilic Fasciitis and Simvastatin Arch Int Med 161:1456-1457, Choquet-Kastylevsky,G.,et al, 2001 HMG-CoA Reductase Inhibitors (Statins) Neurol 54:790-795, Hess,D.C.,et al, 2000 Showing articles 0 to 9 of 9